TNSN07163A1 - Use of androgens to reduce the likelihood of acquiring or to treat skin aging - Google Patents
Use of androgens to reduce the likelihood of acquiring or to treat skin agingInfo
- Publication number
- TNSN07163A1 TNSN07163A1 TNP2007000163A TNSN07163A TNSN07163A1 TN SN07163 A1 TNSN07163 A1 TN SN07163A1 TN P2007000163 A TNP2007000163 A TN P2007000163A TN SN07163 A TNSN07163 A TN SN07163A TN SN07163 A1 TNSN07163 A1 TN SN07163A1
- Authority
- TN
- Tunisia
- Prior art keywords
- likelihood
- loss
- acquiring
- androgens
- reduce
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62411204P | 2004-11-01 | 2004-11-01 | |
PCT/CA2005/001652 WO2006047859A1 (fr) | 2004-11-01 | 2005-10-31 | Utilisation d'androgenes pour retarder le vieillissement de la peau ou traiter celui-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN07163A1 true TNSN07163A1 (en) | 2008-11-21 |
Family
ID=36318842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2007000163A TNSN07163A1 (en) | 2004-11-01 | 2007-04-27 | Use of androgens to reduce the likelihood of acquiring or to treat skin aging |
Country Status (20)
Country | Link |
---|---|
US (1) | US20060178352A1 (fr) |
EP (1) | EP1807062A4 (fr) |
JP (1) | JP2008517952A (fr) |
KR (1) | KR20070073964A (fr) |
CN (1) | CN101094676A (fr) |
AP (1) | AP2007003982A0 (fr) |
AU (1) | AU2005301035A1 (fr) |
BR (1) | BRPI0517950A (fr) |
CA (1) | CA2585666A1 (fr) |
EA (1) | EA200700983A1 (fr) |
GE (1) | GEP20094833B (fr) |
HR (1) | HRP20070183A2 (fr) |
IL (1) | IL182844A0 (fr) |
MA (1) | MA29220B1 (fr) |
MX (1) | MX2007005098A (fr) |
NO (1) | NO20072642L (fr) |
RS (1) | RS20070185A (fr) |
TN (1) | TNSN07163A1 (fr) |
WO (1) | WO2006047859A1 (fr) |
ZA (1) | ZA200703531B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2749235C (fr) | 2004-10-20 | 2014-08-12 | Endorecherche, Inc. | Precurseurs de steroide sexuel, seuls ou combines a un modulateur de recepteur d'oestrogene selectif et/ou a des oestrogenes et/ou a un inhibiteur de phosphodiesterase de type 5 cgmp, pour prevenir et traiter la secheresse vaginale et les dysfonctionnements sexuels chez la femme postmenopausee |
CN101461294B (zh) | 2006-06-01 | 2011-05-18 | 松下电器产业株式会社 | 洗衣机用无刷电动机以及搭载其的洗衣机 |
US8268806B2 (en) | 2007-08-10 | 2012-09-18 | Endorecherche, Inc. | Pharmaceutical compositions |
DE112014004733A5 (de) * | 2013-10-15 | 2016-07-14 | Chelac Holding Gmbh | Steroid-Carbonsäureester, Zusammensetzungen, enthaltend Steroid-Carbonsäureester und Verwendung dieser bei lokal topischer Applikation für kosmetische oder dermatologische Zwecke |
WO2017057743A1 (fr) * | 2015-09-30 | 2017-04-06 | 富士フイルム株式会社 | Composition absorbable par voie transdermique |
JP2022548314A (ja) * | 2019-09-23 | 2022-11-17 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL88180C (fr) * | 1953-08-26 | |||
SK286051B6 (sk) * | 1993-01-19 | 2008-02-05 | Endorecherche Inc. | Použitie prekurzora pohlavného steroidu na prípravu liečiva na prevenciu alebo liečenie znížených alebo nevyrovnaných koncentrácií pohlavných steroidov |
FR2729854A1 (fr) * | 1995-01-26 | 1996-08-02 | Oreal | Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique |
US5736537A (en) * | 1995-09-12 | 1998-04-07 | Estee Lauder, Inc. | Dehydroep:androsterone sailcylate useful against skin atrophy |
US5709878A (en) * | 1996-08-02 | 1998-01-20 | Rosenbaum; Jerry | Transdermal delivery of dehydroepiandrosterone |
US5869090A (en) * | 1998-01-20 | 1999-02-09 | Rosenbaum; Jerry | Transdermal delivery of dehydroepiandrosterone |
AR018660A1 (es) * | 1998-06-11 | 2001-11-28 | Endorech Inc | Una composicion farmaceutica que comprende androst-5-en-3beta,17beta-diol o una prodroga del mismo; un kit y metodos terapeuticos que utilizan dicha composicion y un parche transdermico. |
US6117446A (en) * | 1999-01-26 | 2000-09-12 | Place; Virgil A. | Drug dosage unit for buccal administration of steroidal active agents |
FR2803750B1 (fr) * | 2000-01-17 | 2004-04-02 | Assist Publ Hopitaux De Paris | Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant |
US20040198706A1 (en) * | 2003-03-11 | 2004-10-07 | Carrara Dario Norberto R. | Methods and formulations for transdermal or transmucosal application of active agents |
US20030027804A1 (en) * | 2001-06-27 | 2003-02-06 | Van Der Hoop Roland Gerritsen | Therapeutic combinations for the treatment of hormone deficiencies |
JP2004002321A (ja) * | 2002-03-11 | 2004-01-08 | Takeda Chem Ind Ltd | 性ホルモン依存性疾患治療剤 |
IL157535A0 (en) * | 2003-08-21 | 2004-03-28 | Topimed Ltd | Preparations for the prevention of skin atrophy |
-
2005
- 2005-10-31 RS RSP-2007/0185A patent/RS20070185A/sr unknown
- 2005-10-31 BR BRPI0517950-5A patent/BRPI0517950A/pt not_active IP Right Cessation
- 2005-10-31 EA EA200700983A patent/EA200700983A1/ru unknown
- 2005-10-31 WO PCT/CA2005/001652 patent/WO2006047859A1/fr active Application Filing
- 2005-10-31 KR KR1020077012537A patent/KR20070073964A/ko not_active Application Discontinuation
- 2005-10-31 EP EP05799216A patent/EP1807062A4/fr not_active Withdrawn
- 2005-10-31 MX MX2007005098A patent/MX2007005098A/es not_active Application Discontinuation
- 2005-10-31 AP AP2007003982A patent/AP2007003982A0/xx unknown
- 2005-10-31 AU AU2005301035A patent/AU2005301035A1/en not_active Abandoned
- 2005-10-31 JP JP2007538225A patent/JP2008517952A/ja active Pending
- 2005-10-31 CA CA002585666A patent/CA2585666A1/fr not_active Abandoned
- 2005-10-31 GE GEAP200510104A patent/GEP20094833B/en unknown
- 2005-10-31 CN CNA2005800456687A patent/CN101094676A/zh active Pending
- 2005-11-01 US US11/264,704 patent/US20060178352A1/en not_active Abandoned
-
2007
- 2007-04-27 TN TNP2007000163A patent/TNSN07163A1/fr unknown
- 2007-04-29 IL IL182844A patent/IL182844A0/en unknown
- 2007-04-30 HR HR20070183A patent/HRP20070183A2/xx not_active Application Discontinuation
- 2007-04-30 ZA ZA200703531A patent/ZA200703531B/xx unknown
- 2007-05-23 NO NO20072642A patent/NO20072642L/no not_active Application Discontinuation
- 2007-05-30 MA MA29957A patent/MA29220B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
RS20070185A (en) | 2008-09-29 |
JP2008517952A (ja) | 2008-05-29 |
GEP20094833B (en) | 2009-11-25 |
EA200700983A1 (ru) | 2008-04-28 |
EP1807062A4 (fr) | 2009-06-03 |
AU2005301035A1 (en) | 2006-05-11 |
AP2007003982A0 (en) | 2007-06-30 |
CN101094676A (zh) | 2007-12-26 |
KR20070073964A (ko) | 2007-07-10 |
HRP20070183A2 (en) | 2007-08-31 |
NO20072642L (no) | 2007-07-30 |
BRPI0517950A (pt) | 2008-10-21 |
EP1807062A1 (fr) | 2007-07-18 |
US20060178352A1 (en) | 2006-08-10 |
MX2007005098A (es) | 2008-01-16 |
WO2006047859A1 (fr) | 2006-05-11 |
IL182844A0 (en) | 2007-09-20 |
MA29220B1 (fr) | 2008-02-01 |
CA2585666A1 (fr) | 2006-05-11 |
ZA200703531B (en) | 2008-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006073786A3 (fr) | Compositions opthalmiques comprenant un steroide et une cyclosporine pour le traitement de l'oeil sec | |
MX2007009368A (es) | Metodo para estimular la sintesis de colagena y/o expresion de factor de crecimiento de queratinocitos. | |
TNSN07163A1 (en) | Use of androgens to reduce the likelihood of acquiring or to treat skin aging | |
DE502005010615D1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
WO2005105107A3 (fr) | Traitement hormonal de la sclerose en plaques | |
MX2011008616A (es) | Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. | |
WO2010036947A3 (fr) | Préparations pharmaceutiques à base de lipide(s) à usage oral et topique, leurs compositions, procédés et utilisations | |
TW201129368A (en) | Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions | |
TW200602030A (en) | Use of loteprednol etabonate for the treatment of dry eye | |
MX338512B (es) | Dispositivo para tratamiento médico y/o cosmético. | |
PT2210588E (pt) | Composição expansível, essencialmente isenta de ingredientes farmaceuticamente activos para o tratamento da pele humana | |
HK1098960A1 (en) | Method and composition for treating rhinitis | |
HK1096857A1 (en) | Medicamentously targeted local lipolysis | |
WO2006086693A3 (fr) | Dispositifs medicaux | |
HK1112721A1 (en) | Tissue disruption treatment and composition for use thereof | |
NO20055390L (no) | Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer | |
RS20070399A (en) | Device for the hot-dip coating of a metal strip | |
ATE422892T1 (de) | Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle | |
DE60330888D1 (de) | Verwendung von drospirenon zur behandlung von hypertension | |
TW200511999A (en) | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone | |
WO2009106715A3 (fr) | Peptide derive d'une proteine de la famille des aquaporines | |
NO20071238L (no) | Fremgangsmater for leging av skader ved human IL-18 administrering | |
HK1111924A1 (en) | Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient | |
NO20060655L (no) | 2-alkyliden-19-Nor-vitamin D derivater for behandling av osteofeni eller osteoporose hos hannkjonn | |
WO2003032909A3 (fr) | Methode de traitement de la peau avec des derives de diphosphonate |